HHS's Indian Health Service awards $250K contract for pharmaceutical supplies to McKesson Corporation
Contract Overview
Contract Amount: $250,000 ($250.0K)
Contractor: Mckesson Corporation
Awarding Agency: Department of Health and Human Services
Start Date: 2026-03-24
End Date: 2027-08-23
Contract Duration: 517 days
Daily Burn Rate: $484/day
Competition Type: COMPETED UNDER SAP
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: PHARMACEUTICAL SUPPLIES, OPEN MARKET PURCHASES FOR NSSC CUSTOMERS.
Place of Performance
Location: OKLAHOMA CITY, OKLAHOMA County, OKLAHOMA, 73114
State: Oklahoma Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $250,000 to MCKESSON CORPORATION for work described as: PHARMACEUTICAL SUPPLIES, OPEN MARKET PURCHASES FOR NSSC CUSTOMERS. Key points: 1. McKesson Corporation, a major player, dominates the pharmaceutical distribution market. 2. The contract is competed under SAP, suggesting a streamlined procurement process. 3. Potential risks include price volatility in the pharmaceutical market and supply chain disruptions. 4. Spending falls within the Drugs and Druggists' Sundries Merchant Wholesalers sector.
Value Assessment
Rating: good
The contract value of $250,000 is relatively small. Benchmarking against similar open market purchases for pharmaceutical supplies is difficult without more specific data on the exact items procured. However, the firm fixed price contract suggests price certainty.
Cost Per Unit: N/A
Competition Analysis
Competition Level: limited
The contract was competed under SAP (Simplified Acquisition Procedures), indicating it was likely a competitive process among eligible vendors. This method aims for efficiency in smaller procurements, but the extent of price discovery may be less rigorous than full and open competition.
Taxpayer Impact: The direct taxpayer impact is limited due to the relatively small contract value. The IHS aims to provide essential pharmaceutical supplies, ensuring value for taxpayer dollars spent on healthcare for Native Americans.
Public Impact
Ensures availability of essential medications for IHS customers. Supports healthcare services for Native American communities. Leverages existing procurement systems for efficiency.
Waste & Efficiency Indicators
Waste Risk Score: 48 / 10
Warning Flags
- Potential for price increases in pharmaceutical market
- Reliance on a single large supplier
Positive Signals
- Streamlined procurement process via SAP
- Firm fixed price contract provides cost certainty
Sector Analysis
This contract falls under the Drugs and Druggists' Sundries Merchant Wholesalers sector, a critical component of the healthcare supply chain. Spending benchmarks for pharmaceutical supplies vary widely based on the specific drugs and quantities, but this $250,000 award appears to be for routine operational needs.
Small Business Impact
The data indicates this contract was awarded to McKesson Corporation, a large, established company. There is no specific indication of small business participation in this particular award, which is common for specialized supply contracts in this sector.
Oversight & Accountability
The contract is managed by the Indian Health Service (IHS), a federal agency responsible for providing healthcare to American Indians and Alaska Natives. Oversight would involve monitoring delivery, quality, and adherence to contract terms to ensure taxpayer funds are used effectively.
Related Government Programs
- Drugs and Druggists' Sundries Merchant Wholesalers
- Department of Health and Human Services Contracting
- Indian Health Service Programs
Risk Flags
- Market volatility in pharmaceutical pricing
- Potential supply chain disruptions
- Limited competition due to specialized nature of supplies
- Dependence on a single large supplier
Tags
drugs-and-druggists-sundries-merchant-wh, department-of-health-and-human-services, ok, bpa-call, 100k-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $250,000 to MCKESSON CORPORATION. PHARMACEUTICAL SUPPLIES, OPEN MARKET PURCHASES FOR NSSC CUSTOMERS.
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Indian Health Service).
What is the total obligated amount?
The obligated amount is $250,000.
What is the period of performance?
Start: 2026-03-24. End: 2027-08-23.
What specific pharmaceutical items are included in this contract, and how do their prices compare to market averages?
The provided data does not specify the exact pharmaceutical items procured under this contract. To assess value accurately, a detailed list of the drugs and sundries is needed. Comparing prices against market averages for these specific items would reveal if the $250,000 award represents a fair market price or if there's potential for cost savings through negotiation or alternative sourcing.
What are the primary risks associated with relying on McKesson Corporation for these pharmaceutical supplies?
The primary risks include potential supply chain disruptions affecting McKesson's ability to deliver, price increases due to market fluctuations or McKesson's pricing power, and a lack of immediate alternatives if issues arise. While McKesson is a reliable supplier, dependence on a single large entity can create vulnerabilities that require proactive risk mitigation strategies from the IHS.
How effectively does this contract support the IHS's mission of providing healthcare to its customers?
This contract is crucial for ensuring the consistent availability of necessary pharmaceutical supplies, directly supporting the IHS's mission. By securing these supplies, the IHS can maintain essential healthcare services for its beneficiaries. The firm fixed price and competitive SAP process suggest an effort towards efficient resource allocation for this critical function.
Industry Classification
NAICS: Wholesale Trade › Drugs and Druggists' Sundries Merchant Wholesalers › Drugs and Druggists' Sundries Merchant Wholesalers
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: COMPETED UNDER SAP
Solicitation Procedures: SIMPLIFIED ACQUISITION
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 6535 STATE HIGHWAY 161, IRVING, TX, 75039
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $250,000
Exercised Options: $250,000
Current Obligation: $250,000
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 75H71122A00161
IDV Type: BPA
Timeline
Start Date: 2026-03-24
Current End Date: 2027-08-23
Potential End Date: 2027-08-23 00:00:00
Last Modified: 2026-04-07
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →